摘要
目的:观察康艾注射液联合CTF方案在乳腺癌新辅助化疗中的临床效果。方法:将乳腺癌患者92例按照随机数字的方法分为对照组和观察组各46例,对照组给予CTF的新辅助化疗,观察组在对照组基础上使用康艾注射液,对治疗的效果进行分析。结果:观察组近期治疗效果优于对照组(Z=-2.246,P<0.05)。治疗后,2组患者生活质量量表各维度的数据均增高(P<0.05)。在治疗后的组间比较中,各维度评分均为观察组高于对照组,差异有统计学意义(P<0.05)。各类不良反应的发生率均为对照组高于观察组(P<0.05)。结论:将康艾注射液加入到CTF方案中,对乳腺癌患者施行新辅助化疗,可以提升治疗效果,改善生活质量,降低不良反应。
Objective:To observe the clinical effect of Kang’ai injection combined with CTF regimen on neoadjuvant chemotherapy for breast cancer.Methods:A total of 92 cases of patients with breast cancer were divided into the control group and the observation group according to the random number table method,46 cases in each group.The control group was given neoadjuvant chemotherapy of CTF,and the observation group was additionally treated with Kang’ai injection based on the treatment of the control group.The curative effect was analyzed.Results:The short-term curative effect in the observation group was superior to that in the control group(Z=-2.246,P<0.05).After treatment,all scores in the Quality of Life scale in the two groups were increased(P<0.05).After treatment,each score in the observation group was higher than that in the control group,the difference being significant(P<0.05).The incidence of each adverse reaction in the control group was higher than that in the observation group(P<0.05).Conclusion:Adding Kang’ai injection into the CTF regimen and performing neoadjuvant chemotherapy in treating patients with breast cancer can improve curative effect as well as quality of life,and reduce adverse reactions.
出处
《新中医》
CAS
2019年第11期164-167,共4页
New Chinese Medicine
关键词
乳腺癌
康艾注射液
新辅助化疗
不良反应
Breast cancer
Kang’ai injection
Neoadjuvant chemotherapy
Adverse reactions
